LIFE:CA:TSX-Evolve Global Healthcare Enhanced Yield Fund Hedged Units (CAD)

ETF | Sector Equity |

Last Closing

CAD 21.45

Change

-0.10 (-0.46)%

Market Cap

CAD 0.22B

Volume

9.30K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-29 )

Largest Industry Peers for Sector Equity

Symbol Name Price(Change) Market Cap
TEC:CA TD Global Technology Leaders I..

+0.52 (+1.24%)

CAD 3.04B
ZWU:CA BMO Covered Call Utilities ETF

-0.14 (-1.25%)

CAD 1.92B
XIT:CA iShares S&P/TSX Capped Informa..

+0.40 (+0.67%)

CAD 0.66B
TXF:CA First Asset Tech Giants Covere..

+0.32 (+1.48%)

CAD 0.65B
HTA:CA Harvest Tech Achievers Growth ..

+0.31 (+1.63%)

CAD 0.65B
XHC:CA iShares Global Healthcare (CAD..

-0.31 (-0.42%)

CAD 0.63B
ZUT:CA BMO Equal Weight Utilities Ind..

-0.43 (-1.90%)

CAD 0.55B
CWW:CA iShares Global Water Common Cl..

-0.45 (-0.76%)

CAD 0.33B
XUT:CA iShares S&P/TSX Capped Utiliti..

-0.53 (-1.86%)

CAD 0.33B
COW:CA iShares Global Agriculture Com..

-0.45 (-0.70%)

CAD 0.28B

ETFs Containing LIFE:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Sector Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.17% 17% F 30% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.17% 20% F 33% F
Trailing 12 Months  
Capital Gain 10.06% 20% F 32% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.06% 23% F 35% F
Trailing 5 Years  
Capital Gain 6.45% 17% F 42% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 6.45% 20% F 43% F
Average Annual (5 Year Horizon)  
Capital Gain 0.95% 17% F 38% F
Dividend Return 2.04% 6% D- 36% F
Total Return 1.08% 53% F 39% F
Risk Return Profile  
Volatility (Standard Deviation) 6.90% 97% N/A 82% B
Risk Adjusted Return 29.54% 26% F 48% F
Market Capitalization 0.22B 62% D 47% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.